Related Business Topics
Latest Headlines
Forbes.com - Nov. 23, 2009, 9:38 AM
2-ARCA gets fast-track status for heart drug, s soar - Forbes.com nology Enterprise Personal Emerging nology All Forbes nology & The World nology Thomson Reuters UPDATE 2-ARCA gets fast-track status for heart drug, s soar 11.23.09, 12:25 PM EST * Expects ...
Reuters - Nov. 23, 2009, 9:28 AM
* Expects to submit study protocol for review in Q4 * Shares up 44 pct Nov 23 (Reuters) - ARCA biopharma Inc (ABIO.O) said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending ...
Reuters - Nov. 23, 2009, 9:21 AM
* Expects to submit study protocol for review in Q4 * Shares jump 81 pct (Updates stock movement) Nov 23 (Reuters) - ARCA biopharma Inc (ABIO.O: Quote, Profile, Research) said U.S. health regulators granted a fast-track designation for its experimental ...
Forbes.com - Nov. 23, 2009, 7:47 AM
1012 EST 23Nov2009-ARCA biopharma shares jump on fast-track designation ------------------------------------------------------------------------------ ARCA biopharma Inc shares soared 28.9 percent to $2.90 after the company said U.S. health regulators ...
Forbes.com - Nov. 23, 2009, 7:12 AM
Nov 23 (Reuters) - ARCA biopharma Inc: * Receives FDA fast track designation for Gencaro development in genotype-defined heart failure population ((Bangalore ...
Forbes.com - Nov. 23, 2009, 7:12 AM
* Expects to submit study protocol for review in Q4 * Shares up 44 pct Nov 23 (Reuters) - ARCA biopharma Inc said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its ...
Reuters - Nov. 23, 2009, 7:09 AM
* Expects to submit study protocol for review in Q4 * Shares up 44 pct Nov 23 (Reuters) - ARCA biopharma Inc (ABIO.O) said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending ...
Reuters - Nov. 23, 2009, 6:24 AM
BROOMFIELD, Colo.--(Business Wire)-- ARCA biopharma, Inc. (Nasdaq:ABIO) today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, ...
Forbes.com - Nov. 23, 2009, 6:13 AM
BusinessWire - ARCA biopharma, Inc. (Nasdaq:ABIO) today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of Gencaro(TM), the Company's investigational, pharmacologically ...
